Strota/ Newsroom/ 2026-07-22

RUBICON (RUBICON): Acquisition / M&A

Strota Newsroom · session of 2026-07-22 · 22 Jul 20:01 · RUBICON stock page →

Filing of Scheme of Merger of Kia Health Tech Private Limited (Wholly Owned Subsidiary) with Rubicon Research Limited… Historically, acquisition / m&a events have moved RUBICON-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Rubicon Research has filed a scheme of merger with the exchange to absorb Kia Health Tech Private Limited, its wholly owned subsidiary, according to an NSE filing dated 22 July 2026. The company also announced that its board has fixed 7 August 2026 as the record date for a final dividend of ₹1.50 per equity share for financial year 2025-26, and scheduled the 27th annual general meeting. The merger filing was made under an exemption clause of a SEBI master circular governing disclosure requirements.

Events like this — acquisition or merger announcements — have historically shown a 48.9% win rate across 141 comparable instances in Strota's database, with a net edge of 0.213%. This base rate reflects how similar corporate actions have performed in the past, not a forecast for Rubicon specifically.

The stock currently trades at a price-to-earnings ratio of 95.72 and a price-to-book ratio of 18.75, with a return on equity of 27.0% and earnings per share of ₹15.32. The market capitalisation stands at ₹24,209 crore, and the dividend yield is 0.1%. The Nifty 50 declined 0.79% on the session.

The filing confirms the merger proposal and dividend timeline; it does not establish whether the scheme has received regulatory or shareholder approval, nor does it quantify any financial impact of combining the subsidiary.

The catalyst

Filing of Scheme of Merger of Kia Health Tech Private Limited (Wholly Owned Subsidiary) with Rubicon Research Limited For Disclosure Purposes Only, in terms of the Exemption under Paragraph 4 of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20, 2023 (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

RUBICON right now

P/E 95.72. Full RUBICON analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.